Cargando…
NR1D2 Accelerates Hepatocellular Carcinoma Progression by Driving the Epithelial-to-Mesenchymal Transition
INTRODUCTION: A poor prognosis owing to cancer invasion and metastasis, hepatocellular carcinoma (HCC) is one of the leading causes of malignancy deaths worldwide. A dominant epithelial-to-mesenchymal transition or EMT function in tumour metastasis is substantially evidenced. Prior reports identifie...
Autores principales: | Tong, Hui, Liu, Xiaohui, Li, Tao, Qiu, Weihua, Peng, Chenghong, Shen, Baiyong, Zhu, Zhecheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217318/ https://www.ncbi.nlm.nih.gov/pubmed/32440156 http://dx.doi.org/10.2147/OTT.S237804 |
Ejemplares similares
-
INTS8 accelerates the epithelial-to-mesenchymal transition in hepatocellular carcinoma by upregulating the TGF-β signaling pathway
por: Tong, Hui, et al.
Publicado: (2019) -
MACC1-AS1 promotes hepatocellular carcinoma cell invasion and proliferation by regulating PAX8
por: Tong, Hui, et al.
Publicado: (2020) -
Sirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation
por: Shen, Chuan, et al.
Publicado: (2016) -
Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition
por: Song, Tao, et al.
Publicado: (2018) -
HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition
por: Huan, Hong-bo, et al.
Publicado: (2017)